Telesis Bio Inc.
TBIODelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001850079
Telesis Bio Inc. was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Jul 26, 2024; 21 institutions reported holding it in 13F filings for Q1 2024, worth $4.77M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Telesis Bio Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
TBIO is no longer listed, so this page shows Q1 2024. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 21
- −5 vs. Q4 2023
- Shares held
- 10.8M
- −447.1K (−4.0%) vs. Q4 2023
- Total value
- $4.77M
- +$266.8K (+5.9%) vs. Q4 2023
- New holders
- 1
- 5 more added
- Sold out
- 6
- 5 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $178.5K |
| Q2 2024 | 10 | $2.05M |
| Q1 2024 | 21 | $4.77M |
| Q4 2023 | 26 | $4.50M |
| Q3 2023 | 26 | $12.3M |
| Q2 2023 | 30 | $18.9M |
| Q1 2023 | 28 | $37.3M |
| Q4 2022 | 26 | $15.1M |
| Q3 2022 | 33 | $20.9M |
| Q2 2022 | 39 | $26.1M |
| Q1 2022 | 47 | $92.9M |
| Q4 2021 | 43 | $186.8M |
| Q3 2021 | 43 | $76.8M |
| Q2 2021 | 40 | $138.6M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Telesis Bio Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 100 | $0 | 0.00% | −3,879−97.5% | Reduced |
| Royal Bank of Canada | 127 | $0 | 0.00% | −123−49.2% | Reduced |
| Citigroup Inc | 6 | $3 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 70 | $31 | 0.00% | +1+1.4% | Added |
| Advisor Group Holdings, Inc. | 225 | $99 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 404 | $178 | 0.00% | +400+10,000.0% | Added |
| JPMorgan Chase & Co | 533 | $234 | 0.00% | +23+4.5% | Added |
| Dynamic Wealth Strategies, LLC | 2,470 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,105 | $1.37K | 0.00% | +3,082+13,400.0% | Added |
| Bank of America Corp | 6,000 | $2.64K | 0.00% | −9−0.1% | Reduced |
| Northern Trust Corp | 15,937 | $7.01K | 0.00% | 00.0% | Unchanged |
| DF Dent & Co Inc | 20,000 | $8.80K | 0.00% | +20,000 | New |
| State Street Corp | 21,800 | $9.59K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 24,830 | $10.9K | 0.00% | −1,027−4.0% | Reduced |
| UBS Group AG | 42,763 | $18.8K | 0.00% | +42,471+14,544.9% | Added |
| Vontobel Holding Ltd. | 50,000 | $22.3K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 67,000 | $29.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 83,561 | $36.8K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 232,395 | $102.3K | 0.00% | −65,129−21.9% | Reduced |
| Vanguard Group Inc | 418,293 | $184.0K | 0.00% | 00.0% | Unchanged |
| Northpond Ventures, LLC | 9,844,130 | $4.33M | 4.22% | 00.0% | Unchanged |
| Penbrook Management LLC | 0 | $0 | 0.00% | −354,325−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −37,486−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −27,547−100.0% | Sold out |
| McCarthy Asset Management, Inc. | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,086−100.0% | Sold out |
| DAGCO, Inc. | 0 | $0 | 0.00% | −2,470−100.0% | Sold out |